SELLAS Life Sciences to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase
SELLAS Life Sciences Group (NASDAQ: SLS), a late-stage clinical biopharmaceutical company specializing in cancer therapy development, has announced its participation in the upcoming A.G.P. Virtual Healthcare Company Showcase. The company's President and CEO, Dr. Angelos Stergiou, will engage in a fireside chat scheduled for Wednesday, May 21, 2025, at 8:20 am ET.
SELLAS Life Sciences Group (NASDAQ: SLS), un'azienda biofarmaceutica in fase avanzata di sviluppo clinico specializzata nella terapia oncologica, ha annunciato la sua partecipazione al prossimo A.G.P. Virtual Healthcare Company Showcase. Il Presidente e CEO dell'azienda, Dr. Angelos Stergiou, parteciperà a una conversazione informale prevista per mercoledì 21 maggio 2025, alle 8:20 ET.
SELLAS Life Sciences Group (NASDAQ: SLS), una compañía biofarmacéutica en etapa avanzada de desarrollo clínico especializada en terapias contra el cáncer, ha anunciado su participación en el próximo A.G.P. Virtual Healthcare Company Showcase. El presidente y CEO de la compañía, Dr. Angelos Stergiou, participará en una charla informal programada para el miércoles 21 de mayo de 2025, a las 8:20 am ET.
SELLAS Life Sciences Group (NASDAQ: SLS)는 암 치료 개발에 특화된 후기 임상 단계의 바이오제약 회사로, 다가오는 A.G.P. Virtual Healthcare Company Showcase에 참여한다고 발표했습니다. 회사의 사장 겸 CEO인 Dr. Angelos Stergiou가 2025년 5월 21일 수요일 오전 8시 20분(동부시간)에 예정된 대담에 참여할 예정입니다.
SELLAS Life Sciences Group (NASDAQ : SLS), une société biopharmaceutique en phase clinique avancée spécialisée dans le développement de thérapies contre le cancer, a annoncé sa participation au prochain A.G.P. Virtual Healthcare Company Showcase. Le président-directeur général de la société, Dr. Angelos Stergiou, participera à une discussion informelle prévue le mercredi 21 mai 2025 à 8h20 ET.
SELLAS Life Sciences Group (NASDAQ: SLS), ein biopharmazeutisches Unternehmen in der späten klinischen Phase, das sich auf die Entwicklung von Krebstherapien spezialisiert hat, hat seine Teilnahme an der bevorstehenden A.G.P. Virtual Healthcare Company Showcase bekannt gegeben. Der Präsident und CEO des Unternehmens, Dr. Angelos Stergiou, wird an einem Fireside-Chat teilnehmen, der für Mittwoch, den 21. Mai 2025, um 8:20 Uhr ET geplant ist.
- None.
- None.
NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that Dr. Angelos Stergiou, President and Chief Executive Officer of SELLAS, will participate in a fireside chat at the A.G.P. Virtual Healthcare Company Showcase on Wednesday, May 21, 2025 at 8:20 am ET.
A.G.P. Virtual Healthcare Company Showcase Details:
Format: Fireside chat
Date: Wednesday, May 21, 2025
Time: 8:20 a.m. ET
Webcast Link: Click Here
About SELLAS Life Sciences Group, Inc.
SELLAS is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. SELLAS’ lead product candidate, GPS, is licensed from Memorial Sloan Kettering Cancer Center and targets the WT1 protein, which is present in an array of tumor types. GPS has the potential as a monotherapy and combination with other therapies to address a broad spectrum of hematologic malignancies and solid tumor indications. The Company is also developing SLS009 (tambiciclib) - potentially the first and best-in-class differentiated small molecule CDK9 inhibitor with reduced toxicity and increased potency compared to other CDK9 inhibitors. Data suggests that SLS009 demonstrated a high response rate in AML patients with unfavorable prognostic factors including ASXL1 mutation, commonly associated with poor prognosis in various myeloid diseases. For more information on SELLAS, please visit www.sellaslifesciences.com.
Investor Contact
Bruce Mackle
Managing Director
LifeSci Advisors, LLC
SELLAS@lifesciadvisors.com
FAQ
When is SELLAS Life Sciences (SLS) presenting at the A.G.P. Virtual Healthcare Showcase 2025?
Who will represent SELLAS Life Sciences (SLS) at the A.G.P. Virtual Healthcare Showcase?
What type of company is SELLAS Life Sciences (SLS)?
What is the format of SELLAS Life Sciences' (SLS) presentation at the A.G.P. Healthcare Showcase?
